# US 2020/0370029 A1 · Composition comprising a gene vector that selectively depletes p16 positive senescent cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0370029 A1
- Document ID: US20200370029A1
- Status: Published application
- Kind: A1
- Application number: 16/723,552
- Filed: 2019-12-20
- Published: 2020-11-26
- Earliest claimed: 2012-04-17
- Assignees: Unity Biotechnology, Inc.; Kythera Biopharmaceuticals, Inc.
- Applicants: Unity Biotechnology, Inc.; Kythera Biopharmaceuticals, Inc.
- Inventors: Serge Lichtsteiner; Nathaniel David
- Web page: https://patentgrep.com/patent/US20200370029A1

## CPC

- C12N 9/503: {derived from viruses}
- A61K 38/4873: {Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H}
- C12N 15/85: for animal cells
- C12N 2740/10043: viral genome or elements thereof as genetic vector
- C12N 2740/15043: viral genome or elements thereof as genetic vector
- C12Y 304/22: Cysteine endopeptidases (3.4.22)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12Y: ENZYMES

## Abstract

Polypeptides, viruses, methods and compositions provided herein are useful for the selective elimination of senescent cells. Method aspects include methods for inducing apoptosis in a senescent cell comprising administering to the cell a polynucleotide, virus, host cell, or pharmaceutical composition described herein. Other methods include expressing a pro-apoptotic gene in a senescent cell comprising administering to the cell the polynucleotide, virus, or pharmaceutical composition as described herein.

## Claims

### Claim 1

A composition comprising a conditionally replicating virus in a pharmaceutically compatible excipient, wherein the conditionally replicating virus has a recombinant genome construct in which a replication gene for the virus is placed under transcriptional control of a heterologous promoter,
wherein the heterologous promoter is the p16 promoter,
wherein when the conditionally replicating virus is applied to a mixed cell population comprising target cells that express p16, the p16 promoter causes the virus to replicate preferentially in the target cells, thereby causing lysis of the target cells and selectively depleting them from the cell population.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the genome construct of the conditionally replicating virus comprises more than one heterologous promoter.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the genome construct of the conditionally replicating virus comprises a replication gene for the virus placed under transcriptional control of a chemically inducible promoter.

### Claim 4 (depends on 1)

The composition of claim 1, wherein replication of the virus is tissue specific.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the conditionally replicating virus is an adenovirus.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the conditionally replicating virus is a lentivirus, and the replication gene under transcriptional control of the p16 promoter is selected from gag, pol and env.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the nucleotide sequence of the p16 promoter comprises SEQ. ID NO:1.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the nucleotide sequence of the p16 promoter comprises SEQ. ID NO:2.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the genome of the conditionally replicating virus further comprises a caspase gene under transcriptional control of the p16 promoter.

### Claim 10 (depends on 1)

A method of selectively depleting senescent cells from a mixed cell population or tissue, comprising combining the tissue with a composition according to claim 1 such that the conditionally replicating virus replicates in the senescent cells in the mixed cell population or tissue.
